Christian Brendel

Christian Brendel

Harvard University

H-index: 27

North America-United States

About Christian Brendel

Christian Brendel, With an exceptional h-index of 27 and a recent h-index of 18 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Gene Therapy, Hematopoiesis, HSC biology, Genetic Diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

A Novel High-Titer, Bifunctional Lentiviral Vector for Autologous Hematopoietic Stem Cell Gene Therapy of Sickle Cell Disease

Abstract NG05: Epitope editing enables targeted immunotherapy of acute myeloid leukemia

Epitope Edited Hematopoietic Stem Cells to Enable Synergistic Immunotherapy Combinations for Acute Myeloid Leukemia

UM171 Enhances Fitness and Engraftment of Gene Modified Hematopoietic Stem Cells from Sickle Cells Disease Patients

Epitope Edited Hematopoietic Stem Cells Allow Immune-Based In Vivo Selection of Genome-Engineered Cells

237 Epitope engineered hematopoietic stem cells to enable multi-specificity CAR-T cells for acute myeloid leukemia

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia

Christian Brendel Information

University

Position

Dana-Farber/Boston Children's Hospital Cancer and Blood Disorders Center, Harvard Medical School

Citations(all)

2882

Citations(since 2020)

2006

Cited By

1590

hIndex(all)

27

hIndex(since 2020)

18

i10Index(all)

39

i10Index(since 2020)

34

Email

University Profile Page

Google Scholar

Christian Brendel Skills & Research Interests

Gene Therapy

Hematopoiesis

HSC biology

Genetic Diseases

Top articles of Christian Brendel

A Novel High-Titer, Bifunctional Lentiviral Vector for Autologous Hematopoietic Stem Cell Gene Therapy of Sickle Cell Disease

Molecular Therapy Methods & Clinical Development

2024/4/24

Boya Liu
Boya Liu

H-Index: 0

Christian Brendel
Christian Brendel

H-Index: 19

Abstract NG05: Epitope editing enables targeted immunotherapy of acute myeloid leukemia

Cancer Research

2024/4/5

Epitope Edited Hematopoietic Stem Cells to Enable Synergistic Immunotherapy Combinations for Acute Myeloid Leukemia

Blood

2023/11/28

UM171 Enhances Fitness and Engraftment of Gene Modified Hematopoietic Stem Cells from Sickle Cells Disease Patients

Blood

2023/11/28

Epitope Edited Hematopoietic Stem Cells Allow Immune-Based In Vivo Selection of Genome-Engineered Cells

Blood

2023/11/28

Jing Zeng
Jing Zeng

H-Index: 21

Christian Brendel
Christian Brendel

H-Index: 19

237 Epitope engineered hematopoietic stem cells to enable multi-specificity CAR-T cells for acute myeloid leukemia

2023/11/1

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling

Nature Communications

2023/9/20

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia

Nature

2023/9/14

Swapping the serotype: A novel helper-dependent adenoviral vector platform for in vivo HSC gene therapy

Molecular Therapy-Methods & Clinical Development

2023/9/14

Christian Brendel
Christian Brendel

H-Index: 19

Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells

BioRxiv

2023

Deletion of murine Rhoh leads to de-repression of Bcl-6 via decreased KAISO levels and accelerates a malignancy phenotype in a murine model of lymphoma

Small GTPases

2022/12/31

Targeting a Putative Intronic Splicing Silencer Salvages Expression from the Recurrent SBDS C. 258+ 2T> C Mutant Allele in Shwachman-Diamond Syndrome Patient Cells and Mouse Model

Blood

2022/11/15

Therapeutic Gene Editing of HSCs Ex Vivo without in Vitro Culture Avoids Genotoxicity, Simplifies Procedures, and Preserves Efficiency and Stemness

Blood

2022/11/15

Combining the Anti-Sickling βAS3-Globin Gene with BCL11A and ZNF410 Double Shmirs for the Treatment of Sickle Cell Disease

Blood

2022/11/15

Boya Liu
Boya Liu

H-Index: 0

Christian Brendel
Christian Brendel

H-Index: 19

Induction of fetal hemoglobin and reduction of clinical manifestations in patients with severe sickle cell disease treated with shmir-based lentiviral gene therapy for post …

Blood

2022/11/15

Epitope Engineered Hematopoietic Stem and Progenitor Cells to Enable CAR-T Cell Immunotherapy for Acute Myeloid Leukemia

American Society of Hematology Annual Meeting

2022/11/15

Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies

Molecular Therapy

2022/8/3

Hematopoietic Stem/Progenitor Cells and Engineering: FROM HARMFUL TO USEFUL: EXPLOITING A LEUKEMIC TRANSCRIPTION FACTOR FOR LARGE-SCALE EX VIVO MANUFACTURE OF HUMAN MACROPHAGES

Cytotherapy

2022/5/1

Combined+ 58 and+ 55 BCL11A enhancer editing Yields exceptional efficiency, specificity and HbF induction in human and NHP preclinical models

Blood

2021/11/23

Restored macrophage function ameliorates disease pathophysiology in a mouse model for IL10 receptor-deficient very early onset inflammatory bowel disease

Journal of Crohn's and Colitis

2021/9/1

Christian Brendel
Christian Brendel

H-Index: 19

See List of Professors in Christian Brendel University(Harvard University)